147 related articles for article (PubMed ID: 22901818)
1. Priapism in an infant with sickle cell trait after cardiac transplant.
Bacsu CD; Metcalfe PD
Urology; 2012 Oct; 80(4):928-30. PubMed ID: 22901818
[TBL] [Abstract][Full Text] [Related]
2. Acute and long-term efficacy and safety of sildenafil for the treatment of chronic thromboembolic pulmonary hypertension in a heart transplant recipient.
Zacà V; Padeletti M; Pagliaro A; Furiozzi F; Mondillo S; Favilli R
Pharmacology; 2011; 87(1-2):24-7. PubMed ID: 21178386
[TBL] [Abstract][Full Text] [Related]
3. Potential risks of chronic sildenafil use for priapism in sickle cell disease.
Lane A; Deveras R
J Sex Med; 2011 Nov; 8(11):3193-5. PubMed ID: 21883942
[TBL] [Abstract][Full Text] [Related]
4. Sildenafil for pulmonary hypertension complicating bronchopulmonary dysplasia.
Bhatt-Mehta V; Donn SM
Expert Rev Clin Pharmacol; 2014 Jul; 7(4):393-5. PubMed ID: 24866752
[TBL] [Abstract][Full Text] [Related]
5. Oral sildenafil for persistent pulmonary hypertension early after congenital cardiac surgery in children.
Nemoto S; Sasaki T; Ozawa H; Katsumata T; Kishi K; Okumura K; Mori Y; Umegaki O
Eur J Cardiothorac Surg; 2010 Jul; 38(1):71-7. PubMed ID: 20206543
[TBL] [Abstract][Full Text] [Related]
6. The utility of sildenafil in pulmonary hypertension: a focus on bronchopulmonary dysplasia.
Wardle AJ; Wardle R; Luyt K; Tulloh R
Arch Dis Child; 2013 Aug; 98(8):613-7. PubMed ID: 23625986
[TBL] [Abstract][Full Text] [Related]
7. Bleeding after circumcision in a newborn receiving sildenafil.
Gamboa D; Robbins D; Saba Z
Clin Pediatr (Phila); 2007 Nov; 46(9):842-3. PubMed ID: 17641129
[TBL] [Abstract][Full Text] [Related]
8. Not just for men.
Prat NM; Sánchez-Dalmau BF; Foroozan R
Surv Ophthalmol; 2011; 56(2):173-7. PubMed ID: 21035828
[TBL] [Abstract][Full Text] [Related]
9. Sildenafil and mild pulmonary arterial hypertension: unjustified risks, with no tangible benefit.
Prescrire Int; 2010 Oct; 19(109):206. PubMed ID: 21180373
[No Abstract] [Full Text] [Related]
10. Acute priapism associated with the use of sildenafil in a patient with sickle cell trait.
Kassim AA; Fabry ME; Nagel RL
Blood; 2000 Mar; 95(5):1878-9. PubMed ID: 10744389
[No Abstract] [Full Text] [Related]
11. Pulmonary artery hypertension in heart transplant recipients: how much is too much?
De Santo LS; Romano G; Maiello C; Buonocore M; Cefarelli M; Galdieri N; Nappi G; Amarelli C
Eur J Cardiothorac Surg; 2012 Nov; 42(5):864-9; discussion 869-70. PubMed ID: 22402452
[TBL] [Abstract][Full Text] [Related]
12. Randomized controlled trial of sildenafil for preventing recurrent ischemic priapism in sickle cell disease.
Burnett AL; Anele UA; Trueheart IN; Strouse JJ; Casella JF
Am J Med; 2014 Jul; 127(7):664-8. PubMed ID: 24680796
[TBL] [Abstract][Full Text] [Related]
13. Prevention of Ischemic Priapism in Sickle Cell Disease: Sildenafil: Commentary on: Randomized Controlled Trial of Sildenafil for Preventing Recurrent Ischemic Priapism in Sickle Cell Disease.
Shakeri A; Van Asseldonk B; Elterman DS
Urology; 2015 Dec; 86(6):1055-6. PubMed ID: 26431892
[No Abstract] [Full Text] [Related]
14. Safety and efficacy of transition from subcutaneous treprostinil to oral sildenafil in patients with pulmonary arterial hypertension.
Keogh AM; Jabbour A; Weintraub R; Brown K; Hayward CS; Macdonald PS
J Heart Lung Transplant; 2007 Nov; 26(11):1079-83. PubMed ID: 18022071
[TBL] [Abstract][Full Text] [Related]
15. The effect of sildenafil on retinopathy of prematurity in very preterm infants.
Fang AY; Guy KJ; König K
J Perinatol; 2013 Mar; 33(3):218-21. PubMed ID: 22766743
[TBL] [Abstract][Full Text] [Related]
16. Central retinal vein occlusion in a patient after being commenced on sildenafil citrate for pulmonary arterial hypertension.
Pinto LM; Morekar S; Mahashur AA
Indian J Chest Dis Allied Sci; 2009; 51(4):249-51. PubMed ID: 20073379
[TBL] [Abstract][Full Text] [Related]
17. Partial priapism.
Hoyerup P; Azawi NH
BMJ Case Rep; 2013 Aug; 2013():. PubMed ID: 23933863
[TBL] [Abstract][Full Text] [Related]
18. Sildenafil and pulmonary hypertension in children.
Prescrire Int; 2012 Jul; 21(129):178. PubMed ID: 22852281
[No Abstract] [Full Text] [Related]
19. Daily phosphodiesterase type 5 inhibitor therapy as rescue for recurrent ischemic priapism after failed androgen ablation.
Pierorazio PM; Bivalacqua TJ; Burnett AL
J Androl; 2011; 32(4):371-4. PubMed ID: 21127306
[TBL] [Abstract][Full Text] [Related]
20. Phosphodiesterase 5 (PDE5) inhibition, ANP and NO rapidly reduce epididymal duct contractions, but long-term PDE5 inhibition in vivo does not.
Mietens A; Tasch S; Feuerstacke C; Eichner G; Volkmann J; Schermuly RT; Grimminger F; Müller D; Middendorff R
Mol Cell Endocrinol; 2012 Feb; 349(2):145-53. PubMed ID: 21996373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
